hCD38(2)

品系全名

C57BL/6JSmo-Cd38tm2(CD38)Smoc

目录号

NM-HU-190059

品系状态

活体

导出PDF

基因信息

基因名
CD38

品系描述

通过同源重组,将小鼠基因Cd38进行人源化修饰。原hCD38(NM-HU-00113)小鼠模型因技术原因已下架。
应用领域:免疫治疗;肿瘤研究;药物筛选

验证数据

image.png

Fig1. hCD38 is highly expressed on both B cells and T cells in human PBMC.

image.png

Fig2. m/hCD38 is highly expressed on blood and spleen-derived B cells in hCD38 knockin mice.

image.png

Fig3. m/hCD38 can be detected on blood-derived T cells in hCD38 knockin mice.

image.png


Fig4. m/hCD38 can be detected on spleen-derived T cells in hCD38 knockin mice.

image.png

Fig5. In vivo anti-tumor effect of Daratumumab in hCD38 knockin mice. Homozygous humanized CD38 mice were inoculated with E.G7-OVA T lymphoma cells. The results showed: Daratumumab , a drug targeting human CD38, showed a very significant anti-tumor effect , demonstrating that the humanized CD38 mouse model is a good in vivo model for validating the efficacy of antibodies targeting human CD38.( In cooperation with Crownbio)

image.png

Fig6. Binding assay of Daratumumab to hCD38-derived B cells.( In cooperation with Crownbio)

image.png

Fig7. Binding assay of Daratumumab to hCD38-derived T cells.( In cooperation with Crownbio)


你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看